These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 31897956)

  • 1. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
    Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
    Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Thiel J; Hässler F; Salzer U; Voll RE; Venhoff N
    Arthritis Res Ther; 2013 Sep; 15(5):R133. PubMed ID: 24286362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapies for ANCA-associated Vasculitis.
    Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
    Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.
    Canzian A; Venhoff N; Urban ML; Sartorelli S; Ruppert AM; Groh M; Girszyn N; Taillé C; Maurier F; Cottin V; de Moreuil C; Germain V; Samson M; Jachiet M; Denis L; Rieu V; Smets P; Pugnet G; Deroux A; Durel CA; Aouba A; Cathébras P; Deligny C; Faguer S; Gil H; Godeau B; Lifermann F; Phin-Huynh S; Ruivard M; Bonniaud P; Puéchal X; Kahn JE; Thiel J; Dagna L; Guillevin L; Vaglio A; Emmi G; Terrier B;
    Arthritis Rheumatol; 2021 Mar; 73(3):498-503. PubMed ID: 33001543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
    Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
    Cartin-Ceba R; Fervenza FC; Specks U
    Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
    Yamane T; Hashiramoto A
    Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ANCA-associated vasculitis].
    Krasselt ML; Holle JU
    Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
    Teixeira V; Mohammad AJ; Jones RB; Smith R; Jayne D
    RMD Open; 2019; 5(1):e000905. PubMed ID: 31245051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C; Groh M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
    Hellmich B; Holle J; Moosig F
    Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.
    Akiyama M; Kaneko Y; Takeuchi T
    Autoimmun Rev; 2021 Feb; 20(2):102737. PubMed ID: 33340770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
    Muñoz SA; Gandino IJ; Orden AO; Allievi A
    Reumatol Clin; 2015; 11(3):165-9. PubMed ID: 25523986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How best to manage relapse and remission in ANCA-associated vasculitis.
    Puéchal X; Guillevin L
    Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies.
    Ayan G; Esatoglu SN; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Fresko I; Ozdogan H; Yurdakul S; Hamuryudan V
    Rheumatol Int; 2018 Apr; 38(4):607-622. PubMed ID: 29322343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
    Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
    Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.